19/08/2026
The cold chain is the invisible infrastructure behind every vaccine, every biologic, every advanced therapy, and every clinical trial material that reaches a patient. It does not make headlines. It does not get applause. But when it fails — people notice.
Consider what happens in the background of every successful healthcare outcome:
🌡️ A vaccine is stored at 2–8°C from the moment it leaves the manufacturing facility to the moment it is administered — a journey that may span multiple countries, carriers, and climate zones
💊 A biologic therapy is packaged, conditioned, and shipped within a narrow temperature window — because even a brief excursion can render it ineffective or unsafe
🔬 A patient-specific cell therapy is tracked from collection to infusion — with chain of identity maintained at every step, because there is no replacement
🌍 A clinical trial material crosses borders in compliance with GDP requirements — because a single regulatory gap can invalidate years of research
The pharmaceutical cold chain operates as a shared ecosystem in which manufacturers, airlines, freight forwarders, airports, cold chain solution providers and regulators all play a role. And the healthcare cold chain logistics market — valued at USD 59.97 billion in 2024 — is projected to reach USD 137.13 billion by 2034.
Peli BioThermal have spent decades building the solutions that keep this invisible infrastructure running — validated, compliant, and engineered for the real world.
Because when the infrastructure is invisible, the performance cannot be.
Read more 👇
https://www.pelibiothermal.com/our-story/
Source: Peli BioThermal
🗣️ Talk to us today about temperature-controlled packaging solutions...
💻 www.ccplogistics.com
📧 [email protected]
📲 +966 560 677 333
